Search hospitals > Nebraska > Omaha
Nebraska Methodist Hospital
Claim this profileOmaha, Nebraska 68114
Global Leader in Parotid Gland Cancer
Global Leader in Relapse
Conducts research for Cervical Adenocarcinoma
Conducts research for Ovarian Cancer
Conducts research for Lung Cancer
338 reported clinical trials
12 medical researchers
Summary
Nebraska Methodist Hospital is a medical facility located in Omaha, Nebraska. This center is recognized for care of Parotid Gland Cancer, Relapse, Cervical Adenocarcinoma, Ovarian Cancer, Lung Cancer and other specialties. Nebraska Methodist Hospital is involved with conducting 338 clinical trials across 447 conditions. There are 12 research doctors associated with this hospital, such as Ralph Hauke, MD, Brent Tierney, MD, Timothy Huyck, and Robert M. Langdon.Area of expertise
1Parotid Gland Cancer
Global LeaderStage IV
Stage III
Stage II
2Relapse
Global LeaderStage IV
Stage III
Stage I
Top PIs
Ralph Hauke, MDNebraska Cancer Specialists2 years of reported clinical research
Expert in Prostate Cancer
Studies Prostatic Neoplasm
36 reported clinical trials
74 drugs studied
Brent Tierney, MDNebraska Methodist Hospital2 years of reported clinical research
Expert in Ovarian Cancer
Expert in Parotid Gland Cancer
23 reported clinical trials
42 drugs studied
Timothy HuyckNebraska Methodist Hospital2 years of reported clinical research
Studies Pancreatic Cancer
Studies Cervical Adenocarcinoma
15 reported clinical trials
31 drugs studied
Robert M. LangdonNebraska Methodist Hospital10 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
42 drugs studied
Clinical Trials running at Nebraska Methodist Hospital
Breast Cancer
Ovarian Cancer
Lung Cancer
Parotid Gland Cancer
Pancreatic Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Pancreatic Carcinoma
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Nebraska Methodist Hospital?
Where is Nebraska Methodist Hospital located?
Who should I call to ask about financial aid or insurance network?
What insurance does Nebraska Methodist Hospital accept?
What awards or recognition has Nebraska Methodist Hospital received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.